Cyndeo Wealth Partners’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,275	Closed	-$360K	–	399
2024 Q1	$360K	Buy	5,275 +30	+0.6%	+$2.05K	0.03%	304
2023 Q4	$328K	Buy	+5,245	New	+$328K	0.03%	298